摘要
2014年BG案在美国最高法院作出了裁决,这一裁决预示着第一次有内国国家法院审查了ICSID裁决的合法性问题。这就造成了另外一个问题,基于纽约公约的承认与撤销外国仲裁裁决和ICSID公约拒绝其他非ICSID公约提供的救济方式之间的冲突。ICSID本身在一贯以来的裁决和废除申请机制中,扮演了并不友好的角色,使得其自身独立性和公平性让人质疑。因此,美国的审查虽然不是世界上审查国际仲裁的先例,但仍旧给予ICSID这种本身提供救济方式的纠纷解决机制作出裁决的权威性带来了不小的冲击。为此,中国投资者有必要警惕此种国内审查给既定的国际投资仲裁纠纷带来的不确定性。
BG case was decided by the us Supreme Court in 2014,which indicates that for the first time,a domestic national court has examined the legality of ICSID ruling.This creates another problem,the conflict between recognition under the New York convention and the revocation of foreign arbitral awards and the ICSID convention's refusal to provide remedies under other non-icsid conventions.ICSID itself has played an unfriendly role in the adjudication and abolition mechanism,making its independence and fairness questionable.Therefore,although the us review is not a precedent of reviewing international arbitration in the world,it still has a great impact on the authority of ICSID,a dispute resolution mechanism that provides remedies in its own right,in making decisions.Therefore,it is necessary for Chinese investors to be alert to the uncertainty brought by such domestic review to the established international investment arbitration disputes.
出处
《产业创新研究》
2019年第1期97-100,共4页
Industrial Innovation
关键词
纽约公约
华盛顿公约
救济
国内审查
New York convention
Washington convention
relief
domestic censorship